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CASE REPORT
Coronary artery bypass grafting in a patient with Gilbert syndrome
Gilbert sendromlu bir hastada coroner arter bypass greftlemesi
Kemal Korkmaz1, Hikmet Selçuk Gedik1, Hayati Deniz2
ÖZET
Biz  bu  çalışmamızda;  koroner  arter  bypass  greftleme 
operasyonu yaptığımız koroner arter hastasında, Gilbert 
sendromuna bağlı postoperatif sarılığı sunduk. Sarılık be-
lirti ve bulguları post-operatif birinci günde başlayıp,post-
operatif  yedinci  günde  kendiliğinden  kayboldu.Gilbert 
sendromunun tanısı,özellikleri ve ilişkili diğer anormallik-
ler ile birlikte anestezi ve kardiyopulmoner bypass’ın bili-
rübin metabolizmasına etkileri tartışıldı.
Anahtar kelimeler: Koroner arter hastalığı, koroner arter 
bypass greftleme, Gilbert sendromu
ABSTRACT
Here in we present a case of a postoperative jaundice 
due to Gilbert’s syndrome in a patient who was suffer-
ing from coronary artery disease and undergone coronary 
artery bypass grafting operation. Signs and symptoms of 
jaundice  developed  on  the  postoperative  first  day  and 
resolved spontaneously after 7 days. The diagnosis and 
characteristics  of  Gilbert’s  syndrome  and  other  related 
abnormalities and factors relevant to anesthesia and car-
diopulmonary by-pass, which affect bilirubin metabolism, 
are discussed. J Clin Exp Invest 2012; 3(4): 555-557
Key words: Coronary artery disease, coronary artery by-
pass grafting, Gilbert’s syndrome
INTRODUCTION
Gilbert’s syndrome (GS) is generally considered to 
be an autosomal recessive disorder characterized 
by chronic, non-hemolytic unconjugated hyperbiliru-
binemia in the absence of liver disease. It is caused 
by defects in bilirubin UDP-glucuronosyltransferase 
(UDPGT) and activity is reduced.1 The syndrome is 
usually diagnosed in young adults who present with 
mild,  predominantly  unconjugated  hyperbilirubine-
mia. Electron microscopy of hepatic tissue obtained 
by percutaneous needle biopsy from patients with 
Gilbert’s  syndrome  has  revealed  gross  hypertro-
phy of hepatocyte agranular endoplasmic reticulum 
without any other important abnormality. In Gilbert’s 
Disease bile pigment production increases and also 
there is evidence suggesting impaired hepatic up-
take of bilirubin.2
We report here a case of a patient with Gilbert’s 
Syndrome and discuss other related abnormalities 
and factors relevant to anesthesia and cardiopul-
monary by-pass (CABG) which affect bilirubin me-
tabolism.
CASE
A 62 -year-old woman who was suffering from chest 
pain was attended to the clinic. After same Coro-
nary angiogram revealed two vessel disease and 
CABG was decided. Her pre-operative laboratory 
examinations were as follows: Total bilirubin level: 
9.51mg/dl,  unconjugated  bilirubin  level:  8.87  mg/
dl, conjugated bilirubin level: 0.64 mg/dl and other 
hematologic, biochemical and microbiologic param-
eters were normal. The patient’s anti-HBs was 412 
mlU/mL, HBsAg (-) and anti-HCV (-).
Abdominal  ultrasonography  showed  normal 
liver parenchyma. Echocardiographic examination 
of the heart was also normal.
The  patient  underwent  three  vessel  bypass 
grafting; anterior descending, first diagonal branch 
and  Optus  marginal  branch  of  circumflex  artery, 
respectively.  Coronary  revascularization  was  per-
formed  under  general  anesthesia,  which  was  in-
duced  with  20-mcg/kg  fentanyl  citrate,  0.12  mg/
kg  pancuronium,  2-mg/kg  propofol. After  tracheal Korkmaz et al. Coronary artery bypass in Gilbert syndrome 556
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intubation,  mechanical  ventilation  was  instituted 
with 6-8 ml/kg tidal volume and 10-12 /min respira-
tory rates. Anesthesia was maintained with 10 mcg/
kg of fentanyl and 1 mg/kg propofol as infusion. 2 
mg of pancuronium were given every 45 minutes 
throughout the operation. Aortic and two stage ve-
nous canulla were used to institute the (cardio pul-
monary by-pass) CPB using a roller pump, mem-
brane  oxygenation  and  identical priming  solution. 
Systemic blood flow was maintained at 2,2-2,4 L/
m2, mean arterial blood pressure at 60-70 mm Hg 
during  CPB.  Moderate  hypothermia  (32°C)  was 
applied. Distal anastomoses and proximal anasto-
moses were done during the cross clamp (CC) pe-
riod. The left anterior descending artery was anas-
tomosed with left internal mammarian artery flap. 
The other vessels were anastomosed with greater 
saphenous vein grafts. Aorta cross-clamp time was 
54 minutes and cardio-pulmonary by-pass time was 
76 minutes.
Table 1 and Table 2 shows the patients urea 
and creatinine were doubled and aspartat amino-
transferase (AST), alanin aminotransferase, (ALT) 
levels were increase to ten-fold in the first day after 
operation. Abdominal ultrasonography examination 
of the kidneys was also normal. 
Table 1.  Pre-operative  and  post-operative  biochemical 
parameters
Parameters Pre- Post-operative
operative 1.day 2.day 3.day 10.day
Urea, mg/dL 23 83 158 119 36
Creatinine,
 mg/dL
0.73 1.64 1.87 0.79 0.77
AST, U/L 22 264 995 841 25
ALT, U/L 16 233 1041 766 25
ALP, U/L 88 70 98 96 98
LDH, U/L 215 774 2510 1583 168
Total Bilirubin,
 mg/dL
5.7 8.31 7.81 8.14 6.2
Unconjugated
 Bil, mg/dL
5.47 7.65 7.07 7.35 6.04
Glucose,
 mg/dL
108 153 123 125 118
Other  biochemical  and  hematologic  param-
eters were similar to pre-operative recorded values. 
In  the  third  day  after  CABG, AST, ALT  levels  in-
creased to twenty-fold than decreased gradually. At 
seventh day after the operation AST, ALT, urea and 
creatinine levels were decreased to normal limits. 
Total bilirubin and unconjugated bilirubin levels also 
decreased to pre-operative values.
Table 2. Pre-operative and post-operative hematological 
parameters
Pre- Post-operative
operative 1.day 2.day 3.day 10.day
WBC, K/uL 5.7 30.3 20.2 19.4 7.3
RBC, Mu/L 4.60 3.94 3.88 3.87 4.85
HB, g/dL 14.9 12.0 12.1 12.3 14.5
HCT, % 40.8 35.9 37.9 38.2 43.6
PLT, K/uL 226 60 71 68 235
PT, sc 12.9 17.3 14.1 13.0 13.1
aPTT, sc 23.6 24.9 23.1 22.3 22.6
DISCUSSION
Gilbert’s syndrome is an inherited disorder present 
at birth and 15-45 years of age and is most often 
seen in men. The syndrome exists in 3-10% of the 
U.S.  population.3  Hepatic  tests  and  liver  biopsy’s 
usually normal. Unconjugated bilirubin can increase 
up to 10 mg/dl and a harmless type of jaundice ex-
ists  with  exacerbation  and  remissions  during  the 
disease course. Menstruation, dehydration, fatigue, 
hunger  and  stress  may  exacerbate  the  jaundice 
attacks. To our knowledge this is the first reported 
CABG in a patient with Gilbert’s syndrome in the 
English literature. A significant reverse correlation 
between bilirubin concentration and the prevalence 
of CAD was reported.4-5
On the other hand, both metabolic stress re-
sponse to surgical trauma and/or the side effects of 
the anesthetic medications that are used in CABG 
can cause the relapse of the disease. We think that, 
the  management  of  a  patient,  who  is  suffering  a 
jaundice attack because of the relapse of Gilbert’s 
syndrome, is the same whether the existing risk fac-
tors are evitable or inevitable.
Avoiding hepatotoxic anesthetic agents is man-
datory in these patients. Post-operative care should 
be maintained carefully with multi-discipline evalua-
tion such as gastroenterology. Dehydration should 
be avoided as well. The present case was hydrated 
with  nephramine  and  hepatamine  solutions.6  Spi-
ronolactone should be the drug of choice in need 
of diuresis since loop diuretics may be harmful for 
liver.Korkmaz et al. Coronary artery bypass in Gilbert syndrome 557
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In conclusion, patients with Gilbert’s syndrome 
require careful follow-op during peri- and post-oper-
ative period of CABG.
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